INZY
Price
$6.00
Change
+$0.38 (+6.76%)
Updated
Sep 13 closing price
50 days until earnings call
RIGL
Price
$13.78
Change
+$0.08 (+0.58%)
Updated
Sep 16, 09:30 AM (EDT)
Ad is loading...

INZY vs RIGL

Header iconINZY vs RIGL Comparison
Open Charts INZY vs RIGLBanner chart's image
Inozyme Pharma
Price$6.00
Change+$0.38 (+6.76%)
Volume$399.19K
CapitalizationN/A
Rigel Pharmaceuticals
Price$13.78
Change+$0.08 (+0.58%)
Volume$235
CapitalizationN/A
View a ticker or compare two or three
INZY vs RIGL Comparison Chart
Loading...
INZY
Daily Signalchanged days ago
Gain/Loss if shorted
Show more...
RIGL
Daily Signalchanged days ago
Gain/Loss if shorted
Show more...
VS
INZY vs. RIGL commentary
Sep 16, 2024

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is INZY is a Buy and RIGL is a Sell.

COMPARISON
Comparison
Sep 16, 2024
Stock price -- (INZY: $6.00 vs. RIGL: $13.70)
Brand notoriety: INZY and RIGL are both not notable
Both companies represent the Biotechnology industry
Current volume relative to the 65-day Moving Average: INZY: 143% vs. RIGL: 121%
Market capitalization -- INZY: $402.59M vs. RIGL: $241.05M
INZY [@Biotechnology] is valued at $402.59M. RIGL’s [@Biotechnology] market capitalization is $241.05M. The market cap for tickers in the [@Biotechnology] industry ranges from $606.91B to $0. The average market capitalization across the [@Biotechnology] industry is $3.05B.

Long-Term Analysis

It is best to consider a long-term outlook for a ticker by using Fundamental Analysis (FA) ratings. The rating of 1 to 100, where 1 is best and 100 is worst, is divided into thirds. The first third (a green rating of 1-33) indicates that the ticker is undervalued; the second third (a grey number between 34 and 66) means that the ticker is valued fairly; and the last third (red number of 67 to 100) reflects that the ticker is undervalued. We use an FA Score to show how many ratings show the ticker to be undervalued (green) or overvalued (red).

INZY’s FA Score shows that 0 FA rating(s) are green whileRIGL’s FA Score has 0 green FA rating(s).

  • INZY’s FA Score: 0 green, 5 red.
  • RIGL’s FA Score: 0 green, 5 red.
According to our system of comparison, INZY is a better buy in the long-term than RIGL.

Short-Term Analysis

It is best to consider a short-term outlook for a ticker by using Technical Analysis (TA) indicators. We use Odds of Success as the percentage of outcomes which confirm successful trade signals in the past.

If the Odds of Success (the likelihood of the continuation of a trend) for each indicator are greater than 50%, then the generated signal is confirmed. A green percentage from 90% to 51% indicates that the ticker is in a bullish trend. A red percentage from 90% - 51% indicates that the ticker is in a bearish trend. All grey percentages are below 50% and are considered not to confirm the trend signal.

INZY’s TA Score shows that 5 TA indicator(s) are bullish while RIGL’s TA Score has 3 bullish TA indicator(s).

  • INZY’s TA Score: 5 bullish, 4 bearish.
  • RIGL’s TA Score: 3 bullish, 5 bearish.
According to our system of comparison, INZY is a better buy in the short-term than RIGL.

Price Growth

INZY (@Biotechnology) experienced а +20.48% price change this week, while RIGL (@Biotechnology) price change was +2.85% for the same time period.

The average weekly price growth across all stocks in the @Biotechnology industry was +2.56%. For the same industry, the average monthly price growth was +4.67%, and the average quarterly price growth was -1.44%.

Reported Earning Dates

INZY is expected to report earnings on Nov 05, 2024.

RIGL is expected to report earnings on Aug 06, 2024.

Industries' Descriptions

@Biotechnology (+2.56% weekly)

Biotechnology involves genetic or protein engineering to produce medicines/therapies for treating and preventing ailments. The industry also provides crucial ingredients for diagnostics. This multi-billion-dollar industry is heavily focused on research and development, as companies attempt to continually come up with cutting-edge solutions for health. New discoveries for the treatment of diseases provide opportunities for growth for a company in this industry. Discoveries, however, must pass the regulatory approval from the U.S. Food and Drug Administration (FDA) before they can make it to markets. Amgen Inc., Gilead Sciences, Inc. and Celgene Corporation are examples of companies in this industry.

SUMMARIES
Loading...
FUNDAMENTALS
Fundamentals
INZY($403M) has a higher market cap than RIGL($241M). INZY YTD gains are higher at: 40.845 vs. RIGL (-5.517). RIGL has higher annual earnings (EBITDA): -4.93M vs. INZY (-82.82M). INZY has more cash in the bank: 145M vs. RIGL (49.1M). INZY has less debt than RIGL: INZY (46.7M) vs RIGL (60.3M). RIGL has higher revenues than INZY: RIGL (130M) vs INZY (0).
INZYRIGLINZY / RIGL
Capitalization403M241M167%
EBITDA-82.82M-4.93M1,682%
Gain YTD40.845-5.517-740%
P/E RatioN/AN/A-
Revenue0130M-
Total Cash145M49.1M295%
Total Debt46.7M60.3M77%
FUNDAMENTALS RATINGS
RIGL: Fundamental Ratings
RIGL
OUTLOOK RATING
1..100
64
VALUATION
overvalued / fair valued / undervalued
1..100
85
Overvalued
PROFIT vs RISK RATING
1..100
100
SMR RATING
1..100
100
PRICE GROWTH RATING
1..100
40
P/E GROWTH RATING
1..100
100
SEASONALITY SCORE
1..100
n/a

Tickeron ratings are formulated such that a rating of 1 designates the most successful stocks in a given industry, while a rating of 100 points to the least successful stocks for that industry.

TECHNICAL ANALYSIS
Technical Analysis
INZYRIGL
RSI
ODDS (%)
Bearish Trend 4 days ago
90%
Bearish Trend 4 days ago
89%
Stochastic
ODDS (%)
Bearish Trend 4 days ago
90%
Bearish Trend 4 days ago
86%
Momentum
ODDS (%)
Bullish Trend 4 days ago
90%
Bullish Trend 4 days ago
74%
MACD
ODDS (%)
Bullish Trend 4 days ago
89%
Bearish Trend 4 days ago
80%
TrendWeek
ODDS (%)
Bullish Trend 4 days ago
89%
Bullish Trend 4 days ago
82%
TrendMonth
ODDS (%)
Bullish Trend 4 days ago
87%
Bullish Trend 4 days ago
82%
Advances
ODDS (%)
Bullish Trend 4 days ago
87%
Bullish Trend 12 days ago
83%
Declines
ODDS (%)
Bearish Trend 11 days ago
90%
Bearish Trend 14 days ago
86%
BollingerBands
ODDS (%)
Bearish Trend 4 days ago
90%
Bearish Trend 4 days ago
90%
Aroon
ODDS (%)
N/A
Bullish Trend 4 days ago
83%
View a ticker or compare two or three
Ad is loading...
INZY
Daily Signalchanged days ago
Gain/Loss if shorted
Show more...
RIGL
Daily Signalchanged days ago
Gain/Loss if shorted
Show more...
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
MFs / NAMEPrice $Chg $Chg %
BASAX22.080.36
+1.66%
Brown Advisory Small-Cap Growth Adv
KGIIX14.100.18
+1.29%
Kopernik International I
MECEX14.350.08
+0.56%
NYLI Epoch Capital Growth Class C
URNQX49.020.24
+0.49%
Victory Nasdaq 100 Index R6
NUGIX37.210.10
+0.27%
Nuveen Global Dividend Growth I

INZY and

Correlation & Price change

A.I.dvisor indicates that over the last year, INZY has been loosely correlated with BEAM. These tickers have moved in lockstep 58% of the time. This A.I.-generated data suggests there is some statistical probability that if INZY jumps, then BEAM could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To INZY
1D Price
Change %
INZY100%
+6.76%
BEAM - INZY
58%
Loosely correlated
+7.79%
NTLA - INZY
54%
Loosely correlated
+6.77%
FULC - INZY
51%
Loosely correlated
-7.56%
DNLI - INZY
50%
Loosely correlated
+10.05%
PLRX - INZY
49%
Loosely correlated
+1.35%
More

RIGL and

Correlation & Price change

A.I.dvisor indicates that over the last year, RIGL has been loosely correlated with NTLA. These tickers have moved in lockstep 48% of the time. This A.I.-generated data suggests there is some statistical probability that if RIGL jumps, then NTLA could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To RIGL
1D Price
Change %
RIGL100%
+5.79%
NTLA - RIGL
48%
Loosely correlated
+6.77%
ALLO - RIGL
45%
Loosely correlated
+11.28%
PRME - RIGL
45%
Loosely correlated
+0.99%
RCUS - RIGL
44%
Loosely correlated
+3.22%
INZY - RIGL
43%
Loosely correlated
+6.76%
More